IONIS PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4061
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 32016
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 17817
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17398
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 3362
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3168
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7155
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 565
 
  
 
C07K PEPTIDES 5131

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0073,022 MODULATION OF ALPHA SYNUCLEIN EXPRESSIONApr 18, 17Mar 15, 18[C12N]
2018/0044,673 METHODS FOR MODULATING MECP2 EXPRESSIONMar 03, 16Feb 15, 18[C12N]
2018/0044,676 COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSIONAug 25, 17Feb 15, 18[A61K, C07H, C12N]
2018/0036,335 COMPOSITIONS FOR MODULATING MECP2 EXPRESSIONMar 03, 16Feb 08, 18[A61K, C12N]
2018/0023,077 COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPTJan 06, 16Jan 25, 18[A61K, C12N]
2018/0009,837 COMPOUNDS AND METHODS FOR THE MODULATION OF PROTEINSNov 16, 15Jan 11, 18[C07H, A61K, C12P, C12N]
2018/0010,126 ANTISENSE COMPOUNDS AND USES THEREOFSep 21, 15Jan 11, 18[A61K, C12N]
2018/0002,693 COMPOSITIONS AND METHODSJun 09, 17Jan 04, 18[A61K, C07H, C12N]
2018/0002,695 COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDSJun 21, 17Jan 04, 18[C12N]
2017/0369,883 MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSIONMay 05, 17Dec 28, 17[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920321 Compositions and their uses directed to huntingtinApr 29, 16Mar 20, 18[C07H, C12N]
9914922 Oligomeric compounds comprising bicyclic nucleotides and uses thereofApr 22, 13Mar 13, 18[A61K, C07H, C12N]
9909124 Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profileJun 23, 14Mar 06, 18[A61K, C12N]
9884072 Methods and compositions for modulating apolipoprotein (a) expressionJan 09, 17Feb 06, 18[A61K]
9885045 Methods and compositions for modulating apolipoprotein (a) expressionOct 21, 16Feb 06, 18[C12N]
9885047 Modulation of TMPRSS6 expressionNov 03, 16Feb 06, 18[A61K, C07H, C12N]
9873876 Cancer treatmentNov 21, 16Jan 23, 18[A61K, C12N]
9856473 Compositions and methods for modulation of LMNA expressionJun 25, 14Jan 02, 18[C12N]
9845467 Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animalsMar 04, 16Dec 19, 17[A61K, C12N]
9845468 Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animalsMar 04, 16Dec 19, 17[A61K, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0145,424 COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDSAbandonedJun 08, 15May 25, 17[A61K, C12N]
2016/0348,100 MODULATION OF TRANSTHYRETIN EXPRESSIONAbandonedApr 06, 16Dec 01, 16[C12Q, C12N]
2016/0245,858 INTERCHANGEABLE TEST PANELS FOR USE IN AUTOMATED TEST EQUIPMENTAbandonedFeb 25, 15Aug 25, 16[G01R]
2016/0237,432 METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPTAbandonedOct 14, 14Aug 18, 16[C12N]
2016/0230,172 COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPTAbandonedOct 14, 14Aug 11, 16[C12N]
2016/0222,389 MODULATORS OF COMPLEMENT FACTOR BAbandonedSep 12, 14Aug 04, 16[C12N]
2016/0186,174 SUBSTITUTED MORPHOLINO COMPOUNDS ANALOGS THEREOF AND OLIGOMERIC COMPOUNDS PREPARED THEREFROMAbandonedDec 29, 15Jun 30, 16[C12N]
2016/0160,280 METHODS OF PREDICTING TOXICITYAbandonedNov 04, 15Jun 09, 16[C12Q]
2016/0060,626 MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSIONAbandonedAug 10, 15Mar 03, 16[C12Q, C12N]
2016/0053,256 COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTINAbandonedMay 11, 15Feb 25, 16[C12N]
2016/0017,324 CHIMERIC OLIGOMERIC COMPOUNDS AND THEIR USE IN GENE MODULATIONAbandonedJun 22, 15Jan 21, 16[C12N]
2016/0010,086 OLIGOMERIC COMPOUNDS AND EXCIPIENTSAbandonedDec 02, 14Jan 14, 16[A61K, C12N]
2016/0002,624 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONSAbandonedMay 17, 13Jan 07, 16[C12N]
2015/0322,428 COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDSAbandonedJun 18, 13Nov 12, 15[C12N]
2015/0315,579 DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATIONAbandonedFeb 06, 15Nov 05, 15[C12N]
2015/0315,580 COMPOUNDS AND METHODS FOR IMPROVING CELLULAR UPTAKE OF OLIGOMERIC COMPOUNDSAbandonedMar 05, 15Nov 05, 15[C12N]
2015/0291,960 MODULATION OF CD40 EXPRESSIONAbandonedNov 17, 14Oct 15, 15[C12N]
2015/0292,015 SELECTIVE REDUCTION OF ALLELIC VARIANTSAbandonedMar 03, 15Oct 15, 15[C12Q]
2015/0275,208 SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOFAbandonedOct 11, 13Oct 01, 15[C12N]
2015/0191,727 BICYCLIC CYCLOHEXOSE NUCLEIC ACID ANALOGSAbandonedMar 18, 15Jul 09, 15[C07H, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.